Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Medtech 360 | Market Analysis | US | 2017

Upcoming changes to the US health care policy and reimbursement landscape proposed by CMS, along with new product launches (including the highly anticipated BVS), greater patient selection scrutiny, and slipping ASPs, will continue to place downward pressure on the large, yet contracting, US IC market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the US, with market projections across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Interventional Cardiology Devices – Market Insights – Middle East (Supplemental)
The MESA IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive…
Report
Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2025
The Latin American IC device market has recovered from the COVID-19 pandemic and is reverting to prepandemic growth trends. Increasing patient pool, launch of newer generation devices and…
Report
Interventional Cardiology Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally…